img

Global Therapeutic Proteins and Oral Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Therapeutic Proteins and Oral Vaccines Market Research Report 2024

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
According to Mr Accuracy reports new survey, global Therapeutic Proteins and Oral Vaccines market is projected to reach US$ 634.7 million in 2029, increasing from US$ 426 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Therapeutic Proteins and Oral Vaccines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Therapeutic Proteins and Oral Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Segment by Type
Therapeutic Proteins
Oral Vaccines

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Therapeutic Proteins and Oral Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Therapeutic Proteins
1.2.3 Oral Vaccines
1.3 Market by Application
1.3.1 Global Therapeutic Proteins and Oral Vaccines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Proteins and Oral Vaccines Market Perspective (2018-2029)
2.2 Therapeutic Proteins and Oral Vaccines Growth Trends by Region
2.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Proteins and Oral Vaccines Historic Market Size by Region (2018-2024)
2.2.3 Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Proteins and Oral Vaccines Market Dynamics
2.3.1 Therapeutic Proteins and Oral Vaccines Industry Trends
2.3.2 Therapeutic Proteins and Oral Vaccines Market Drivers
2.3.3 Therapeutic Proteins and Oral Vaccines Market Challenges
2.3.4 Therapeutic Proteins and Oral Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue
3.1.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue (2018-2024)
3.1.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Players (2018-2024)
3.2 Global Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Proteins and Oral Vaccines Revenue
3.4 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio
3.4.1 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Proteins and Oral Vaccines Revenue in 2022
3.5 Therapeutic Proteins and Oral Vaccines Key Players Head office and Area Served
3.6 Key Players Therapeutic Proteins and Oral Vaccines Product Solution and Service
3.7 Date of Enter into Therapeutic Proteins and Oral Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Proteins and Oral Vaccines Breakdown Data by Type
4.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Type (2018-2024)
4.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2024-2029)
5 Therapeutic Proteins and Oral Vaccines Breakdown Data by Application
5.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Application (2018-2024)
5.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
6.2 North America Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
6.4 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
7.2 Europe Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
7.4 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
8.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2024)
8.4 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
9.2 Latin America Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
9.4 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
10.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
10.4 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Therapeutic Proteins and Oral Vaccines Introduction
11.1.4 Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Therapeutic Proteins and Oral Vaccines Introduction
11.2.4 Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.2.5 Amgen Recent Development
11.3 Biogen
11.3.1 Biogen Company Detail
11.3.2 Biogen Business Overview
11.3.3 Biogen Therapeutic Proteins and Oral Vaccines Introduction
11.3.4 Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.3.5 Biogen Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Detail
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Introduction
11.4.4 Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.4.5 Eli Lilly and Company Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Therapeutic Proteins and Oral Vaccines Introduction
11.5.4 Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.5.5 Roche Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Detail
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Introduction
11.6.4 Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.6.5 Johnson and Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Therapeutic Proteins and Oral Vaccines Introduction
11.7.4 Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.7.5 Merck Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Detail
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Introduction
11.8.4 Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.8.5 Novo Nordisk Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Introduction
11.9.4 Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.9.5 Pfizer Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Introduction
11.10.4 Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.10.5 Sanofi Recent Development
11.11 Serum Institute of India
11.11.1 Serum Institute of India Company Detail
11.11.2 Serum Institute of India Business Overview
11.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Introduction
11.11.4 Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.11.5 Serum Institute of India Recent Development
11.12 Emergent Biosolutions
11.12.1 Emergent Biosolutions Company Detail
11.12.2 Emergent Biosolutions Business Overview
11.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Introduction
11.12.4 Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.12.5 Emergent Biosolutions Recent Development
11.13 TransAlgae
11.13.1 TransAlgae Company Detail
11.13.2 TransAlgae Business Overview
11.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Introduction
11.13.4 TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.13.5 TransAlgae Recent Development
11.14 MigVax
11.14.1 MigVax Company Detail
11.14.2 MigVax Business Overview
11.14.3 MigVax Therapeutic Proteins and Oral Vaccines Introduction
11.14.4 MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.14.5 MigVax Recent Development
11.15 Lumen Bioscience
11.15.1 Lumen Bioscience Company Detail
11.15.2 Lumen Bioscience Business Overview
11.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Introduction
11.15.4 Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.15.5 Lumen Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Therapeutic Proteins
Table 3. Key Players of Oral Vaccines
Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2018-2024)
Table 8. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2024-2029)
Table 10. Therapeutic Proteins and Oral Vaccines Market Trends
Table 11. Therapeutic Proteins and Oral Vaccines Market Drivers
Table 12. Therapeutic Proteins and Oral Vaccines Market Challenges
Table 13. Therapeutic Proteins and Oral Vaccines Market Restraints
Table 14. Global Therapeutic Proteins and Oral Vaccines Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Therapeutic Proteins and Oral Vaccines Market Share by Players (2018-2024)
Table 16. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2022)
Table 17. Ranking of Global Top Therapeutic Proteins and Oral Vaccines Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Therapeutic Proteins and Oral Vaccines Product Solution and Service
Table 21. Date of Enter into Therapeutic Proteins and Oral Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2018-2024)
Table 25. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2024-2029)
Table 27. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2018-2024)
Table 29. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2024-2029)
Table 31. North America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Therapeutic Proteins and Oral Vaccines Product
Table 49. Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Therapeutic Proteins and Oral Vaccines Product
Table 54. Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Biogen Company Detail
Table 57. Biogen Business Overview
Table 58. Biogen Therapeutic Proteins and Oral Vaccines Product
Table 59. Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 60. Biogen Recent Development
Table 61. Eli Lilly and Company Company Detail
Table 62. Eli Lilly and Company Business Overview
Table 63. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product
Table 64. Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 65. Eli Lilly and Company Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Therapeutic Proteins and Oral Vaccines Product
Table 69. Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Johnson and Johnson Company Detail
Table 72. Johnson and Johnson Business Overview
Table 73. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product
Table 74. Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 75. Johnson and Johnson Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Therapeutic Proteins and Oral Vaccines Product
Table 79. Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Novo Nordisk Company Detail
Table 82. Novo Nordisk Business Overview
Table 83. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product
Table 84. Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 85. Novo Nordisk Recent Development
Table 86. Pfizer Company Detail
Table 87. Pfizer Business Overview
Table 88. Pfizer Therapeutic Proteins and Oral Vaccines Product
Table 89. Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Sanofi Company Detail
Table 92. Sanofi Business Overview
Table 93. Sanofi Therapeutic Proteins and Oral Vaccines Product
Table 94. Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Serum Institute of India Company Detail
Table 97. Serum Institute of India Business Overview
Table 98. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product
Table 99. Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 100. Serum Institute of India Recent Development
Table 101. Emergent Biosolutions Company Detail
Table 102. Emergent Biosolutions Business Overview
Table 103. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product
Table 104. Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 105. Emergent Biosolutions Recent Development
Table 106. TransAlgae Company Detail
Table 107. TransAlgae Business Overview
Table 108. TransAlgae Therapeutic Proteins and Oral Vaccines Product
Table 109. TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 110. TransAlgae Recent Development
Table 111. MigVax Company Detail
Table 112. MigVax Business Overview
Table 113. MigVax Therapeutic Proteins and Oral Vaccines Product
Table 114. MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 115. MigVax Recent Development
Table 116. Lumen Bioscience Company Detail
Table 117. Lumen Bioscience Business Overview
Table 118. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product
Table 119. Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 120. Lumen Bioscience Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Proteins and Oral Vaccines Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Therapeutic Proteins and Oral Vaccines Market Share by Type: 2022 VS 2029
Figure 3. Therapeutic Proteins Features
Figure 4. Oral Vaccines Features
Figure 5. Global Therapeutic Proteins and Oral Vaccines Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Therapeutic Proteins and Oral Vaccines Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Therapeutic Proteins and Oral Vaccines Report Years Considered
Figure 11. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Therapeutic Proteins and Oral Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Therapeutic Proteins and Oral Vaccines Market Share by Region: 2022 VS 2029
Figure 14. Global Therapeutic Proteins and Oral Vaccines Market Share by Players in 2022
Figure 15. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2022
Figure 17. North America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 19. United States Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 23. Germany Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Region (2018-2029)
Figure 31. China Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 39. Mexico Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 43. Turkey Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Abbott Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 46. Amgen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 47. Biogen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 48. Eli Lilly and Company Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 49. Roche Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 50. Johnson and Johnson Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 51. Merck Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 52. Novo Nordisk Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 53. Pfizer Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 54. Sanofi Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 55. Serum Institute of India Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 56. Emergent Biosolutions Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 57. TransAlgae Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 58. MigVax Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 59. Lumen Bioscience Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries